KEY FEATURES
Full Name | Focal Adhesion Kinase |
---|---|
Synonym | PTK2; FADK; FAK1; Pp125FAK; PPP1R71; Protein Tyrosine Kinase 2; Focal adhesion kinase-related nonkinase; Protein phosphatase 1 regulatory subunit 71 |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.15-10ng/mL |
Sensitivity | 0.06ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human FAK in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human FAK. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human FAK and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human FAK, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human FAK. You can calculate the concentration of Human FAK in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human FAK ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.55 | 1.42 | 4.44 | 0.51 | 1.49 | 4.25 |
Standard deviation | 0.03 | 0.07 | 0.24 | 0.03 | 0.08 | 0.15 |
CV(%) | 5.65 | 4.62 | 5.46 | 6.36 | 5.48 | 3.53 |
RECOVERY
The recovery of Human FAK spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 89-101 | 95 |
EDTA plasma (n=8) | 87-100 | 93 |
Cell culture media (n=8) | 90-107 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human FAK in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with FAK ELISA Kits
SRC ELISA Kit | publications with FAK and SRC |
PXN ELISA Kit | publications with FAK and PXN |
CRK ELISA Kit | publications with FAK and CRK |
BCAR1 ELISA Kit | publications with FAK and BCAR1 |
GRB2 ELISA Kit | publications with FAK and GRB2 |
PTPN11 ELISA Kit | publications with FAK and PTPN11 |
TGFB1I1 ELISA Kit | publications with FAK and TGFB1I1 |
ITGB3 ELISA Kit | publications with FAK and ITGB3 |
TLN1 ELISA Kit | publications with FAK and TLN1 |
Pathways associated with FAK ELISA Kit
Alpha6-Beta4 Integrin Signaling Pathway | Alpha6-Beta4 Integrin Signaling Pathway |
Amoebiasis Pathway | Amoebiasis Pathway |
Androgen Receptor Signaling Pathway | Androgen Receptor Signaling Pathway |
Angiogenesis Pathway | Angiogenesis Pathway |
Apoptosis Pathway | Apoptosis Pathway |
Apoptotic Cleavage Of Cellular Proteins Pathway | Apoptotic Cleavage Of Cellular Proteins Pathway |
Apoptotic Execution Phase Pathway | Apoptotic Execution Phase Pathway |
Axon Guidance Pathway | Axon Guidance Pathway |
Diseases associated with FAK ELISA Kit
Neoplasm Invasiveness | publications with FAK and Neoplasm Invasiveness |
Neoplasm Metastasis | publications with FAK and Neoplasm Metastasis |
Breast Neoplasms | publications with FAK and Breast Neoplasms |
Adenocarcinoma | publications with FAK and Adenocarcinoma |
Lung Diseases | publications with FAK and Lung Diseases |
Lung Neoplasms | publications with FAK and Lung Neoplasms |
Neoplasms, Experimental | publications with FAK and Neoplasms, Experimental |
Liver Diseases | publications with FAK and Liver Diseases |
Cardiovascular Diseases | publications with FAK and Cardiovascular Diseases |
Liver Neoplasms | publications with FAK and Liver Neoplasms |
Organs/Tissues associated with FAK ELISA Kit
Vascular | publications with FAK and Vascular |
Blood | publications with FAK and Blood |
Muscle | publications with FAK and Muscle |
Brain | publications with FAK and Brain |
Kidney | publications with FAK and Kidney |
Lung | publications with FAK and Lung |
Bone | publications with FAK and Bone |
Liver | publications with FAK and Liver |
Embryonic Tissue | publications with FAK and Embryonic Tissue |
Heart | publications with FAK and Heart |